{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:44:13Z","timestamp":1786167853724,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10384-026-01336-1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:26:13Z","timestamp":1772090773000},"page":"876-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["One-year outcomes of pneumatic displacement for submacular hemorrhage secondary to neovascular age-related macular degeneration"],"prefix":"10.1007","volume":"70","author":[{"given":"Kanako","family":"Itagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-9232","authenticated-orcid":false,"given":"Ryo","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuju","family":"Sekiryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"1336_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-9394(14)75575-8","volume":"109","author":"SR Bennett","year":"1990","unstructured":"Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhagef. Am J Ophthalmol. 1990;109:33\u20137.","journal-title":"Am J Ophthalmol"},{"key":"1336_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41433-018-0239-4","volume":"33","author":"A Al-Hity","year":"2019","unstructured":"Al-Hity A, Steel DH, Yorston D, Gilmour D, Koshy Z, Young D, et al. Incidence of submacular haemorrhage (SMH) in Scotland: a Scottish Ophthalmic Surveillance Unit (SOSU) study. Eye. 2019;33:486\u201391.","journal-title":"Eye"},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","volume":"94","author":"H Glatt","year":"1982","unstructured":"Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762\u201373.","journal-title":"Am J Ophthalmol"},{"key":"1336_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00417-024-06671-y","volume":"263","author":"M Ohji","year":"2025","unstructured":"Ohji M. Submacular hemorrhage: my personal journey to the goal. Graefes Arch Clin Exp Ophthalmol. 2025;263:901\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1336_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020367","volume":"13","author":"F Confalonieri","year":"2024","unstructured":"Confalonieri F, Ferraro V, Barone G, Di Maria A, Petrovski B\u00c9, Vallejo Garcia JL, et al. Outcomes in the treatment of subretinal macular hemorrhage secondary to age-related macular degeneration: a systematic review. J Clin Med. 2024;13:367.","journal-title":"J Clin Med"},{"key":"1336_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100010064022","volume":"113","author":"HE Ibanez","year":"1995","unstructured":"Ibanez HE. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol. 1995;113:62.","journal-title":"Arch Ophthalmol"},{"key":"1336_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/0301-4738.36481","volume":"55","author":"M Gopalakrishan","year":"2007","unstructured":"Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A. Pneumatic displacement of submacular hemorrhage. Indian J Ophthalmol. 2007;55:451\u20135.","journal-title":"Indian J Ophthalmol"},{"key":"1336_CR8","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","volume":"33","author":"M Fujikawa","year":"2013","unstructured":"Fujikawa M, Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, et al. Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator. Retina. 2013;33:1908\u201314.","journal-title":"Retina"},{"key":"1336_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/eye.2009.271","volume":"24","author":"M McKibbin","year":"2010","unstructured":"McKibbin M, Papastefanou V, Matthews B, Cook H, Downey L. Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration. Eye. 2010;24:994\u20138.","journal-title":"Eye"},{"key":"1336_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archopht.122.4.477","volume":"122","author":"The Eye Diseases Prevalence Research Group","year":"2004","unstructured":"The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477.","journal-title":"Arch Ophthalmol"},{"key":"1336_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ajo.2011.10.016","volume":"153","author":"SB Bloch","year":"2012","unstructured":"Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-13.e2.","journal-title":"Am J Ophthalmol"},{"key":"1336_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15-22.e2.","journal-title":"Am J Ophthalmol"},{"key":"1336_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data. Ophthalmology. 2020;127:616\u201336.","journal-title":"Ophthalmology"},{"key":"1336_CR14","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1111\/aos.14676","volume":"99","author":"SC Cho","year":"2021","unstructured":"Cho SC, Cho J, Park KH, Woo SJ. Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age\u2010related macular degeneration. Acta Ophthalmol (Copenh). 2021;99:e706\u201314.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"1336_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","volume":"169","author":"JH Cho","year":"2016","unstructured":"Cho JH, Ryoo N-K, Cho KH, Park SJ, Park KH, Woo SJ. Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2016;169:79\u201388.","journal-title":"Am J Ophthalmol"},{"key":"1336_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg Visual Acuity Test. Investig Ophthalmol Vis Sci. 2006;47:1236.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1336_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271447","volume":"17","author":"N Inoue","year":"2022","unstructured":"Inoue N, Kato A, Araki T, Kimura T, Kinoshita T, Okamoto F, et al. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: a retrospective multicenter survey. PLoS ONE. 2022;17:e0271447.","journal-title":"PLoS ONE"},{"key":"1336_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1336_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000537953","volume":"247","author":"SKH Szeto","year":"2024","unstructured":"Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, et al. Displacement of submacular hemorrhage using subretinal cocktail injection versus pneumatic displacement: a real-world comparative study. Ophthalmologica. 2024;247:118\u201332.","journal-title":"Ophthalmologica"},{"key":"1336_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274508","volume":"17","author":"T Kimura","year":"2022","unstructured":"Kimura T, Araki T, Yasukawa T, Kato A, Kuwayama S, Kinoshita T, et al. Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: a multicenter survey from the Japan Clinical Retina Study (J-CREST) group. PLoS ONE. 2022;17:e0274508.","journal-title":"PLoS ONE"},{"key":"1336_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00417-011-1649-1","volume":"249","author":"T Mizutani","year":"2011","unstructured":"Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, et al. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2011;249:1153\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1336_CR22","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s00417-024-06453-6","volume":"262","author":"MM Hosokawa","year":"2024","unstructured":"Hosokawa MM, Ouchi C, Shiode Y, Kimura S, Matoba R, Morita T, et al. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2024;262:3099\u2013107.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1336_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082175","volume":"11","author":"Y Kitagawa","year":"2022","unstructured":"Kitagawa Y, Shimada H, Mori R, Tanaka K, Wakatsuki Y, Onoe H, et al. One-year outcome of intravitreal tissue plasminogen activator, ranibizumab, and gas injections for submacular hemorrhage in polypoidal choroidal vasculopathy. J Clin Med. 2022;11:2175.","journal-title":"J Clin Med"},{"key":"1336_CR24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00417-022-05922-0","volume":"261","author":"T Wakabayashi","year":"2023","unstructured":"Wakabayashi T, Hara C, Shiraki A, Shiraki N, Sayanagi K, Sakimoto S, et al. Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2023;261:1545\u201352.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1336_CR25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41433-022-02096-1","volume":"37","author":"GWM Chew","year":"2023","unstructured":"Chew GWM, Ivanova T, Patton N, Dhawahir-Scala F, Jasani KM, Turner G, et al. Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy. Eye (Lond). 2023;37:1178\u201384.","journal-title":"Eye (Lond)"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01336-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:22:57Z","timestamp":1786166577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01336-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Itagaki, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Chugai); R.Mukai, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Santen, Chugai, Alcon, Novartis, HOYA, Wakamoto, Kowa, Bayer, Allergan, Otsuka, AbbVie, Astellas, Roche); J. Honjo, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Chugai); T. Sekiryu, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Santen, Chugai, Alcon, Novartis, HOYA, Wakamoto, Kowa, Bayer, Allergan, Acura, AbbVie).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}